CAZ-AVI Vs Meropenem in Treatment of Nosocomial Pneumonia

• Research type

  Research Study

• Full title

  Phase III, Randomized, Multicentre, Double-blind, Double-dummy, Parallel-group Comparative Study to Determine the Efficacy, Safety And Tolerability of Ceftazidime-Avibactam (CAZ-AVI) Versus Meropenem in the Treatment of Nosocomial Pneumonia (NP) Including Ventilator-Associated Pneumonia (VAP) in Hospitalised Adults

• IRAS ID

  123496

• Contact name

  Achyut Guleri

• Contact email

  Dr.Guleri@bfwhospitals.nhs.uk

• Sponsor organisation

  AstraZeneca AB

• Eudract number

  2012-004006-96

• ISRCTN Number

  To be registered

• REC name

  Wales REC 2

• REC reference

  13/WA/0101

• Date of REC Opinion

  7 Jun 2013

• REC opinion

  Further Information Favourable Opinion